Drugs / SRT-015
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04887038 Comparator | May 2021 → Feb 2022 | metabolic dysfunction-associated steatohepatitis | Syneos Health | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SRT-015 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04887038 ↗ |
| Route | Oral | “single oral escalating dose of SRT-015 or placebo” NCT04887038 ↗ |